Europe — EMA

Ondansetron Galvany Pharma

Ondondansetron, the active ingredient in Ondansetron Galvany Pharma, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Galvany Pharma, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Galvany Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron used for?

Ondansetron is a selective 5‑HT3 receptor antagonist that acts on the central nervous system and the gastrointestinal tract to prevent vom - Chemotherapy‑induced nausea and vomiting (CINV): ... t t .... g ",

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →